首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

2077598

Phenobarbital市場：依適應症、劑型、通路和地區分類

Phenobarbital Market, By Indication, By Dosage Form, By Distribution Channel, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，Phenobarbital市值將達到 18.3 億美元，到 2033 年將達到 26.1 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 5.2%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	18.3億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.20%	2033年市場規模預測：	26.1億美元

Phenobarbital是一種用於治療和預防癲癇發作的藥物。它的作用機制是調節大腦中導致癲癇發作的異常電活動。它是一種抗驚厥鎮靜劑。此外，它還可以幫助焦慮或壓力過大的人放鬆或入睡。此藥需憑醫生處方箋購買。

長期服用此藥有許多風險，包括影響體內某些營養素（如鈣、B群維生素、葉酸和維生素D）的代謝和吸收。它還可能降低血液中磷酸鹽的含量，而磷酸鹽是維持細胞正常功能所必需的電解質。此外，長期服用此藥還會導致甲狀腺激素失調。

市場動態

Phenobarbital因其治療癲癇和癲癇發作的有效性而聞名。它被認為是多種類型癲癇的第一線治療藥物，尤其是在醫療資源有限的地區。該藥物有效抑制癲癇發作的能力推動了其市場需求和使用。

由於副作用較少、安全性較高的抗癲癇藥物的出現，Phenobarbital市場正受到限制。作用機制各異、適應症不同的新藥的研發，意味著如今治療癲癇和癲癇發作性疾病的選擇更多了。醫療專業人員可能會選擇處方這些新藥而非Phenobarbital，尤其是在需要最大限度減少副作用和藥物交互作用的情況下。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球Phenobarbital市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
全球Phenobarbital市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球Phenobarbital市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 印度
- 中國
- 日本
- 澳洲
- ASEAN
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Sanofi
- Pfizer Inc
- Novartis AG.
- Lundbeck A/S
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals
- Cipla Ltd.
- Par Pharmaceutical
- Analysts'Views

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI6024

Phenobarbital Market is estimated to be valued at USD 1.83 Bn in 2026 and is expected to reach USD 2.61 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1.83 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.20%	2033 Value Projection:	USD 2.61 Bn

Phenobarbital is a medicine which is used to treat or prevent seizures. It works by regulating the abnormal electrical activity in the brain that causes seizures. It is a class of medications called anticonvulsants and sedatives. It is also sometimes used for to help a person relax or sleep when he/she is anxious or nervous. This medication is available only with a doctor's prescription.

There is risk associated with the use of this medication if it is used for a long time. These include problems with how the body uses or absorbs certain nutrients (e.g., calcium, B vitamins, folic acid, and vitamin D). It can also lower the blood levels of phosphate, an electrolyte that is important for normal cell function. Long-term use of this medication can also cause problems with thyroid hormones.

Market Dynamics

Phenobarbital is well-known for its effectiveness in the management of epilepsy and seizure disorders. It is regarded as a first-line treatment for several types of seizures, especially in areas with limited resources. The drug's ability to effectively stop seizures fuels demand for and use of it on the market.

The market for phenobarbital is constrained by the availability of substitute anti-epileptic medications with enhanced safety profiles and fewer adverse effects. There are additional alternatives for treating epilepsy and seizure disorders which is due to the development of new drugs with various mechanisms of action and focused indications. Especially, in situations when limiting adverse effects or drug interactions is important, healthcare practitioners may choose to prescribe these newer medications over phenobarbital.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global phenobarbital market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Pfizer Inc., Novartis AG, H. Lundbeck A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Cipla Ltd., and Par Pharmaceutical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global phenobarbital market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global phenobarbital market

Global Phenobarbital Market Detailed Segmentation:

By Indication (Revenue, USD Bn, 2021 - 2033)
Epilepsy
Neonatal Seizures
By Dosage Form (Revenue, USD Bn, 2021 - 2033)
Tablets
Capsules
Injectables
By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top Companies in the Global Phenobarbital Market
Sanofi
Pfizer Inc.
Novartis AG
Lundbeck A/S
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Hikma Pharmaceuticals
Cipla Ltd.
Par Pharmaceutical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Increasing prevalence of epilepsy
- Restraints
  - Availability of alternative anti-epileptic Drugs
  - Adverse effects and safety concerns
- Opportunities
  - Increasing prevalence of neonatal seizures
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Phenobarbital Market, By Indication, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Neonatal Seizures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Phenobarbital Market, By Dosage Form, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Phenobarbital Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Phenobarbital Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - India
  - China
  - Japan
  - Australia
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033 (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novartis AG.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Lundbeck A/S
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Sun Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Hikma Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cipla Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Par Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Analysts' Views